Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Inarigivir Soproxil in Non-cirrhotic, HBeAg-negative Chronic HBV
NCT04023721Phase 2Terminated
- Sponsor
- F-star
- Start
- Jun 2019
- Primary completion
- Jul 2020
- Modality
- Small Molecules
- Countries
- 2
01
Overview
A Phase 2 trial of inarigivir soproxil in Chronic Hepatitis B (CHB), sponsored by F-star. Started Jun 2019; status: terminated.
02
Drugs
inarigivir soproxil
03
Conditions
Chronic Hepatitis B (CHB)
Beyond the preview
Go deeper on NCT04023721.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04023721.